Contents
Academic literature on the topic 'Rayons alpha – Emploi en thérapeutique'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Rayons alpha – Emploi en thérapeutique.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Dissertations / Theses on the topic "Rayons alpha – Emploi en thérapeutique"
Supiot, Stéphane. "Radioimmunothérapie alpha du myélome multiple." Nantes, 2005. http://archive.bu.univ-nantes.fr/pollux/show.action?id=1073f171-2a75-4520-bb19-dbc21457bb18.
Full textAlpha-radioimmunotherapy can vectorize an alpha particle emitter to target cancer cells. We developed this technique for the treatment of multiple myeloma, with the goal of determining the best suited modalities for later clinical studies. A first step determined the antibody and the radionuclide best suited for radioimmunotherapy and to better understand the mechanisms of alpha-radioimmunotherapy induced cell death. We observed some difference in the radiosensitivity of cell lines and decided in a second step to increase the efficacy of alpha-radioimmunotherapy by combining chemotherapeutic drugs. We found a synergistic effect between alpha-RIT and paclitaxel or doxorubicin. In a third and last step, we analysed the K-ras pathway in order to understand signal transduction following alpha-radioimmunotherapy
Bourquard, Pascal. "Effets de l'interferon-alpha sur le comportement des cellules myélomateuses." Montpellier 1, 1992. http://www.theses.fr/1992MON11042.
Full textPlourde, Guillaume. "Évaluation quantitative de l'exposition à la radiation en cardiologie interventionnelle : approche transradiale et facteurs techniques." Doctoral thesis, Université Laval, 2017. http://hdl.handle.net/20.500.11794/27673.
Full textCoronary artery disease is the leading cause of mortality throughout the world. Percutaneous coronary interventions are increasingly used as diagnostic and therapeutic tools applied to patient care. The use of X-rays is mandatory to perform these procedures. The side effects of radiation exposure are amongst the risks to which patients undergoing a percutaneous coronary intervention are exposed. In order to minimize these risks, one must identify and optimize factors influencing radiation exposure. Amongst them, the radial vascular access site has been inconsistently associated with an increased exposure, even if it is increasingly adopted worldwide as the primary access site. Other factors have also been identified, yet a clinical classification based on their optimization potential by the physician at patient’s bedside remains to be described. The aims of this thesis were identification of technical factors that could be modified at patient’s bedside and formulation of clinical recommendations influencing patient’s radiation exposure. Four independent and complementary projects have been proposed targeting revascularization strategy, catheters number and type, fluoroscopy acquisition rate and vascular access site as potential factors influencing radiation exposure. All studies were lead at Institut universitaire de cardiologie et de pneumologie de Québec. Fluoroscopy time and dose-area product were used as surrogate indicators of radiation exposure. Our results imply that the revascularization strategy did not influence radiation exposure, but that the use of a multiple catheters approach and a 7.5 images per second low-rate fluoroscopy were associated with a reduction of patient’s radiation exposure. Transradial access was associated with a modest increase in radiation exposure when compared with transfemoral access, but the clinical significance of this small increase is uncertain and unlikely to outweigh the clinical benefits of transradial access. In conclusion, identification of technical factors associated with a reduction in radiation exposure enables the formulation of clinical recommendations aiming at risk minimization for the patient and encourages good radiation protection practices.
Montastruc, Marion. "Traitement de la leucémie myéloi͏̈de chronique par l'interféron alpha 2b recombinant en première intention." Bordeaux 2, 1990. http://www.theses.fr/1990BOR23082.
Full textMorin, Jacqueline. "Traitement des hépatites virales chroniques par les interférons 2 alpha." Paris 5, 1990. http://www.theses.fr/1990PA05P085.
Full textPenchinat, Jack. "Le traitement de la leucémie à tricholeucocytes par l'interferon alpha, expérience montpelliéraine." Montpellier 1, 1988. http://www.theses.fr/1988MON11360.
Full textChieregato, Laurence. "Traitement de l'hépatite chronique non-A, non-B parl'interféron alpha 2b recombinant." Paris 5, 1990. http://www.theses.fr/1990PA05P028.
Full textConquet, Marielle. "Le traitement des hépatites virales chroniques C par les interférons alpha, l'activité sérique des transaminases est-elle le seul reflet de l'efficacité : à propos d'une étude." Paris 5, 1994. http://www.theses.fr/1994PA05P037.
Full textEsther, Corine. "Traitement de la leucémie myéloide chronique par l'interféron alpha-2 et l'hydroxyurée avec ou sans cytosine-arabinoside." Paris 5, 1992. http://www.theses.fr/1992PA05P249.
Full textBonhoure, Carole. "Evaluation médico-économique du traitement de l'hépatite C par l'interféron a." Paris 5, 1992. http://www.theses.fr/1992PA05P253.
Full textBooks on the topic "Rayons alpha – Emploi en thérapeutique"
Cameron, Marion D. F.S. Pepperdene: Pioneer radiologist & x-ray martyr. Windsor, Ont: Electa Press, 1994.
Find full textR, Besson Jean-Marie, and Guilbaud G, eds. Towards the use of noradrenergic agonists for the treatment of pain: Proceedings of the International Symposium on Towards the Use of Noradrenergic Agonists for the Treatment of Pain, held in Versailles, France, 20-21 March 1992. Amsterdam: Excerpta Medica, 1992.
Find full text